IEC 62366-1:2015 Demystified – Essential Usability Testing for Medical Devices

Kamiya Crabtree
Medical phone software being used to communicate with a monitor placed on a mans skin.

Creating a usability file is a crucial part of the product development process for medical devices, including Software as a Medical Device (SaMD), to ensure user-centred design and safety. IEC 62366-1 provides a structured approach to ensure that devices are designed with the user in mind and that potential risks associated with their use are identified and mitigated.

What is IEC 62366? A Crucial Standard for Medical Device Usability

According to ISO, ‘IEC 62366 specifies a process for a manufacturer to analyse, specify, develop and evaluate the useability of a medical device as it relates to safety. The first edition of IEC 62366-1, together with the first edition of IEC 62366-2, cancels and replaces the first edition of IEC 62366 published in 2007 and its Amendment 1 (2014)

  1. IEC 62366-1 — Application of usability engineering to medical devices
  2. IEC 62366-2 — Guidance on the application of usability to engineering to medical devices

This guideline provides medical device manufacturers with a structured approach to integrate human factors, supporting them in assessing, defining, creating, and testing the usability of their medical devices.

What exactly should be included in a Usability Engineering File? How can you ensure that all the requirements outlined in the standard are met? What steps do you need to take to ensure compliance? These are common questions that many people face when beginning to create their usability files. By understanding the essential components and requirements, you’ll be well-equipped to develop a comprehensive Usability Engineering File that meets all necessary standards and helps ensure your medical device is both safe and effective for use.

A diagram showing the IEC 62366 process.

Step 1: Define the Scope

This encompasses the specific user group, the intended purpose, and the context in which the device will be utilised.

Intended Users: Who will be using the device? This could include healthcare professionals, patients, or other relevant parties.

Intended Use: What is the device designed to accomplish? This refers to the specific tasks the device is intended for, such as monitoring, diagnosing, or therapeutic applications.

Use Environment: Where will the device be used? The setting can significantly influence the device’s usability, whether it’s intended for use in a home environment or a clinical/hospital setting.

Step 2: Conducting a Risk Analysis

IEC 62366-1 mandates that you perform a comprehensive risk analysis to identify potential use-related hazards—situations where user errors may lead to harm or malfunction of the device.

Hazard Identification: Identify potential hazards that may result from user errors or design flaws. For example, in a medical device like a ventilator, if the user interface is poorly designed, a healthcare professional could mistakenly adjust the settings, leading to inappropriate ventilation rates for the patient. This could result in either hypoventilation (insufficient oxygen delivery) or hyperventilation (excessive oxygen delivery), both of which could cause severe harm to the patient.

Risk Assessment: Assess the likelihood and severity of harm associated with each identified hazard. This involves evaluating whether a specific user action could result in patient harm, an incorrect diagnosis, or delayed treatment, ensuring that risks are appropriately managed and mitigated.

Step 3: Define User Interface (UI) Design Requirements

Following the analysis of user needs and risks, the next crucial step is to establish UI design requirements tailored to the target user group. Chapter 5.2. requires you to identify, as part of the risk analysis, all parts and characteristics of the User Interface that are related to the safety of the medical device.

User Capabilities: Consider the cognitive, physical, and sensory abilities of the users. For instance, if the device is intended for elderly patients, ensure the interface is intuitive, with large text and simplified navigation.

Design Guidelines: These should focus on clear labelling, well-organised controls, alarms, and instructions for use (IFU). Specific adaptations may be necessary for certain groups, such as non-professional users or individuals with visual impairments.

Task Optimisation: Structure the UI to reduce the likelihood of user error. Important tasks should be straightforward to access and perform, eliminating unnecessary steps that could lead to mistakes.

Step 4: Formative Evaluations

The formative evaluation section involves the testing of early prototypes or even design concepts with users in order to identify any potential problems prior to the final design being confirmed and completed. Once risks are identified, this process will repeat until these are mitigated.

User Testing: Carry out usability testing with representative users to assess the device’s interface and interaction design. This could involve techniques such as cognitive walkthroughs, task analysis, and heuristic evaluations to identify potential issues and areas for improvement.

Were critical use errors found? Are further product improvements necessary? If you have answered “yes” to either of these questions at this point, go back as far as necessary in the Usability Engineering process and iterate through it from this point on until no new and critical problems occur during use. If this is the case, you are ready for the last big step: performing the summative evaluation.

Step 5: Summative Evaluation

The goal is to prove that the medical device (and its Interface) can be used without unacceptable residual risks for users, patients, and third parties. The hazard-related use scenarios previously defined are tested.

The summative evaluation focuses on validating the final design to ensure that the device meets the defined usability goals and operates safely and effectively in real-world conditions.

Final Usability Testing: Conduct usability testing on the final version of the device to confirm that it functions as expected and that users can interact with it safely. This typically involves more realistic use scenarios, which may take place in clinical or home environments.

Task Performance Metrics: Evaluate whether users can complete key tasks successfully, such as using the device without errors, interpreting information accurately, and following safety instructions correctly. These metrics help ensure the device’s usability and overall safety in practical use.

Step 6: Post-Market Surveillance (PMS) and Usability Monitoring

Once the product has been released to the market, ongoing monitoring of its usability is crucial. Post-market surveillance helps to identify any emerging issues or areas where improvements can be made.

Incident Reporting: Set up a system to collect feedback and reports related to user issues. This should include complaints, adverse events, or any usability failures encountered by users.

Usability Improvements: If usability issues are identified after the product has been launched, they should be addressed through iterative improvements or design updates to enhance performance and user experience.

Step 7: Compiling the Usability File

The Usability Engineering File should provide a thorough and organised record of the entire usability process, from initial risk analysis and design specifications to testing and post-market surveillance. It is essential that the file demonstrates full compliance with the usability requirements of IEC 62366-1, showing that every step has been taken to guarantee the device’s safety and effectiveness.

The file should include:

  • The device’s scope and intended use
  • A detailed hazard analysis and risk assessment
  • Clear design specifications and user interface requirements
  • Results from formative and summative testing
  • A post-market plan for ongoing usability monitoring

Your Path to IEC 62366 Compliance: Key Takeaways

The Usability Engineering process, as meticulously outlined in IEC 62366-1, plays a crucial role in ensuring the safety and effectiveness of medical devices. By closely integrating with Risk Management, this process helps manufacturers identify and address potential use-related hazards that could jeopardise user safety, patient health, or device performance. Effective implementation, alongside comprehensive documentation, is not only vital for regulatory compliance but also for minimising the risks associated with human error. Ultimately, the goal is to create devices that are intuitive, safe, and reliable and that can stand up to real-world challenges. Following the steps of the Usability Engineering process ensures that these objectives are met and that safety is prioritised in every phase of development.

Standards like IEC 62366-1:2015 are just one part of the increasingly complex regulatory landscape facing medical device companies. At Mantra Systems, we specialise in helping you navigate these challenges with clarity and confidence.

Whether you’re preparing a technical file, responding to questions from a notified body, or working toward approval, our team provides practical, tailored support at every stage. We offer strategic guidance across regulatory frameworks, assist with technical documentation, and help you stay aligned with evolving requirements.

If you’re looking for a trusted partner to take the pressure out of compliance, get in touch with Mantra Systems today.

Related articles

  1. Video poster frame for Episode 2 of our ongoing series.

    Clinical Evaluation Masterclass: Appraisal of literature sources has not been conducted properly - Episode 2

    Our ongoing series covers one of the most frequent reasons for CER rejection: a poor appraisal of literature sources.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  2. A lone figure navigates a rocky coastline.

    Navigating CAPA Terminology: Key Terms for Medical Device Professionals

    We define and explain the language required to work within a Quality Management System (QMS).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  3. Video poster frame for Episode 1 of our new series.

    Clinical Evaluation Masterclass: Overcoming Non-conformities - Episode 1

    In this series, we work step-by-step through common Non-Conformities to ensure you are always ahead of possible challenges on the way to MDR approval.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  4. A man carefully steps across a cliff-face. An analogy for assessing risk.

    Top 5 Common Pitfalls to Avoid During Risk Assessment

    Learn how to sidestep costly mistakes which manufacturers commonly make. From hazard ID to post-market surveillance, we help you improve safety and speed up approvals.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  5. A label maker printing bar-code labels.

    Labelling 101: A Comprehensive Overview for Medical Device Manufacturers

    Labelling and packaging are critical elements to ensuring safety, compliance, and ease of use.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  6. An illustration of a brain-shaped object on an abstract background.

    European Commission Guidelines on Prohibited Artificial Intelligence Practices

    Summary of the 8 AI practices prohibited by the EU 2024/1689 artificial intelligence (AI) Act.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  7. A compass being used to navigate across mountainous countryside.

    Navigating Non-Conformities in Technical Documentation

    We explore how to manage non-conformities effectively and implement Corrective and Preventive Actions (CAPAs).

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  8. A photograph of a literal maze that we're using as a clever metaphor.

    Mastering the EU MDR: Essential Steps for Compliance-Ready Docs

    If you're uncertain about the readiness of your EU MDR documentation, this article provides an overview of the essential steps to ensure you’re on track.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  9. An illustration showing scientists at work.

    A Guide to Electronic Instructions for Use (eIFU)

    Electronic Instructions for Use (eIFUs) are set to revolutionise how medical device instructions are delivered. We explore what this means for you.

    Dr Will Brambley Dr Will Brambley Lead Medical Writer
  10. Two helicopters look as if they are about to collide: An analogy for risk.

    Navigating Risk Management Requirements under the EU MDR

    This is a cornerstone of EU MDR 2017/745, requiring a continuous, well-documented approach. We unpack key requirements and provide actionable strategies.

    Peter Boxall Peter Boxall Lead Medical Writer
  11. A doctor operates a tablet computer.

    Beyond the Acronyms: Understanding SaMD and SiMD

    As software advancements continue, the line between traditional hardware-centric medical devices and software-driven solutions becomes increasingly blurred.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  12. A team of profesional-looking people sit around a table, congratulating themselves.

    Extending the Validity of your IVDD Certificates – Key Dates

    The EU and the MHRA have extended the validity of IVDD certificates, allowing you more time to transition to the IVDR. We explain what this means for manufacturers.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  13. A team of profesional-looking people sit around a table, congratulating themselves.

    GSPR 1: A New Era of Performance with Safety at the Core

    This regulation emphasizes risk management, durable design & biocompatibility to ensure medical devices are safe and effective. GSPR 1 protects users while driving innovation in medical technology.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  14. Cybersecurity Vulnerabilities in Medical Devices: FDA Alerts on Contec and Epsimed Monitors

    Patients can be exposed to risks when devices are online. We explore implications for EU MDR/IVDR cybersecurity requirements, including MDCG guidance

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  15. A futuristic-looking factory full of labelled cardboard boxes.

    Decoding UDI: Your Ultimate Guide to Smarter Medical Device Labelling

    The Unique Device Identifier (UDI) ensures medical device traceability and compliance. We break down its structure, Device Identifier (UDI-DI), Production Identifier (UDI-PI) and its role in EUDAMED.

    Kamiya Crabtree Kamiya Crabtree Regulatory Medical Writer
  16. A hospital room full of equipment with futuristic user interfaces.

    IMDRF Sets the Standard: 10 Key Principles for AI-enabled Medical Devices

    Good Machine Learning Practice (GMLP) principles ensure safe devices, covering intended use, clinical evaluation & Human-AI Interaction (HAII).

    Ron Sangal Ron Sangal Lead Medical Writer
  17. A medical team discuss performance data at their desktop computer.

    Key Updates for Navigating EMDN: MDCG 2024-2 Rev.1 & 2021-12 Rev.1

    Release of the updated guidance helps manufacturers navigate the EMDN system for accurate device classification, ensuring market access.

    Ron Sangal Ron Sangal Lead Medical Writer
  18. A dated monitor for medical equipment.

    Understanding Clinical Evidence Requirements with MDCG 2020-6

    How can manufacturers ensure legacy devices meet MDR's stringent requirements? Discover how MDCG 2020-6 guidance simplifies the path to compliance.

    Dr Clare Dixon Dr Clare Dixon Regulatory Specialist
  19. A stethoscope laid on a desk of regulatory documentation.

    Clinical benefits of an in vitro diagnostic medical device

    How to determine the clinical benefit of an IVD and successfully incorporate it into regulatory documentation.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  20. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  21. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  22. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  23. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  24. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  25. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  26. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  27. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  28. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  29. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  30. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  31. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  32. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  33. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  34. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  35. Literature Search, SOTA Review and Clinical Evaluation

    Literature Search, SOTA Review process and Clinical Evaluation

    We help to demystify the process of systematic search & review of literature for Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  36. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  37. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  38. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  39. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  40. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  41. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  42. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  43. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  44. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  45. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  46. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  47. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  48. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  49. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  50. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  51. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Contact us today